Press release
Investigation announced for Long-Term Investors in shares of Eli Lilly and Company (NYSE: LLY)
An investigation on behalf of investors in Eli Lilly and Company (NYSE: LLY) shares over potential wrongdoing at Eli Lilly and Co.
Investors who purchased shares of Eli Lilly and Company (NYSE: LLY) a have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Eli Lilly and Company (NYSE: LLY officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
In August 2020, Eli Lilly and Company began a clinical trial to test whether adding the Company's antibody-based drug, LY-CoV555, to remdesivir would benefit patients diagnosed with COVID-19.
On October 13, 2020, the trial's sponsor, the National Institute of Allergy and Infectious Diseases ("NIAID") recommended that the trial be paused after an analysis of safety data found "an overall difference in clinical status between the group receiving LY-CoV555 and the group receiving saline placebo."
Shares of Eli Lilly and Company (NYSE: LLY) declined from $157.15 per share on October 9, 2020 to as low as $142.24 per share on October 19, 2020.
Those who purchased shares of Eli Lilly and Company (NYSE: LLY) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Eli Lilly and Company (NYSE: LLY) here
News-ID: 2184159 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Eli
Epic Eli Returns with Emotionally Charged Single 'Blindfold'
Independent hip-hop artist and genre-blurring storyteller Epic Eli is back with "Blindfold," a deeply personal and reflective new single arriving August 1st on all major streaming platforms. Stripped-back yet impactful, "Blindfold" trades heavy synths for vulnerability, beginning with raw acoustic guitar chords before gradually building into a moody, modern trap beat - a sonic metaphor for the emotional unraveling that unfolds in the lyrics.
"Blindfold" explores the disillusionment that follows emotional…
Eli Primmer Has done it again!
Eli Primmer released his latest single ""Running This town" earlier today (April 5th, 2024) And even though it's an a capella song, it immediately became a hit!
Fans have commented that this song is their NEW FAVOURITE, and that they're even more excited for the release of Eli Primmer's upcoming album! ""Running this town" is Primmer's way of telling the haters to ""back off" and how he's running this town so…
Eli Primmer's new album!
Eli Primmer Set to Release New Album, "Timeless Happiness". Singer-songwriter Eli Primmer has announced the forthcoming release of his highly anticipated new album, "Timeless Happiness." The album is scheduled to drop on June 23, 2024, and is a captivating blend of pop and R&B sensibilities. Encompassing 11 tracks, "Timeless Happiness" showcases Primmer's signature blend of infectious melodies, heartfelt lyrics, and production excellence. The album is a journey through love, loss,…
Cannabis Testing Market by Top Key Players - Agilent Technologies, Perkin Elmer, …
Cannabis testing defines various drug test methods for the usage of cannabis in medical prescription, sports medicine, and law. The rapidly increasing applications of cannabis (marijuana) in mainstream medicine such as pain management is poised to increase demand for cannabis testing measures.
Get Sample Copy of this Report @ https://www.bigmarketresearch.com/request-sample/2872404?utm_source=RK&utm_medium=OPR
The Cannabis Testing Market research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data and…
Insulin Pen Market 2017- Novo Nordisk , Eli Lilly , Sanofi
Insulin Pen Market is likely to reach more than US$ 12 Billion across the ten major markets (10MM) of the United States, France, Germany, Italy, Spain, United Kingdom, Japan, China, India and Brazil by the year end of 2022.
Market growth can be attributed to factors such as growing diabetes patient population, high adoption rate, user–friendly design, rising popularity among consumers, help avoid over/under–dosing of insulin, rising market demand for human…
Global Raloxifene Hydrochloride Market 2017 - Eli Lilly, InvaGen Pharmaceuticals
The report entitled Global Raloxifene Hydrochloride Market 2017 presents key insights into the global Raloxifene Hydrochloride market along with the latest up-to-date industry details and forthcoming Raloxifene Hydrochloride industry trends, which will assist the readers to focus on product specification and end users driving the overall market revenue and profitability.
Report Keynotes:
The main motive of the report on "Global Raloxifene Hydrochloride Market 2017" is to study comprehensive details of the market…
